Pharmaceutical companies boost their investment in biologic drugs
Experts from Navarra's pharmaceutical industry meet at the University of Navarra
PHOTO: Manuel Castells
"The finding of new therapeutic targets and the advance of new technologies are driving investment in the global market for biologic drugs". specialization program This was emphasized by Dámaso Molero, director general manager of 3P Biopharmaceuticals, during the closing ceremony of the 11th edition of the University of Navarra's Official Industrial and Galenic Pharmacy Course (EFIG), in which eight new specialists in drug manufacturing, control, development and regulation were trained.
The expert pointed out that in the U.S. alone "more than 180 billion dollars have been invested in this market". He also pointed out that emerging countries such as China, India, South Korea, Japan and Singapore "offer great opportunities for specialists in Industrial and Galenic Pharmacy".
The School of Pharmacy of the University of Navarra brought together specialists from the pharmaceutical industry of Navarra, including Francisco Aranda, director of Quality and Regulatory Affairs of Cinfa, who insisted on the employment possibilities of this profile: "The development of new drugs is a bet that pharmaceutical companies are promoting and for this they will require professionals specialized in its implementation". submission After the awarding of diplomas, Adela López de Cerain, dean of the academic center, concluded the event.
A specialization program with 100% of employment rateThe EFIG is a postgraduate program accessed through spanish pharmacy residency program and is only taught in 4 Spanish universities. The University of Navarra was the only private university accredited by the Ministry of Health, Social Services and Equality.
According to Fernando Martínez, its manager professor , this training prepares students to work "in relevant positions in the pharmaceutical industry in Departments such as production, technical management, quality control and assurance, preformulation and research and development galenic. They can also occupy positions at public administration, within the Spanish Medicines Agency". A range of possibilities that is reflected in the high employment rate of specialists, which stands at 100%.
Students of the XI Official Industrial and Galenic Pharmacy Course specialization program
María Escalada de la Victoria
Sara Hidalgo Sanz
Xaidé López Santillan
Andoni Pérez García de Motiloa
Saioa Santos Vizcaino
Carolina Vallina Granda
Marc Vidal Alba
Celia Vidondo Sola